{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T15:14:35Z","timestamp":1776525275148,"version":"3.51.2"},"reference-count":21,"publisher":"Japan Society of Histochemistry & Cytochemistry","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Histochem. Cytochem.","Acta Histochemica et Cytochemica","Acta Histochem. Cytochem"],"published-print":{"date-parts":[[2025,4,26]]},"DOI":"10.1267\/ahc.24-00053","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T22:06:21Z","timestamp":1743631581000},"page":"93-100","source":"Crossref","is-referenced-by-count":1,"title":["Immunohistochemical Study of the Localization of Ibrutinib-Protein Conjugates in the Rat Gastrointestinal Tract"],"prefix":"10.1267","volume":"58","author":[{"given":"Hiroto","family":"Kataoka","sequence":"first","affiliation":[{"name":"Applied Life Science Department, Faculty of Biotechnology and Life Science, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Saita","sequence":"additional","affiliation":[{"name":"Applied Life Science Department, Faculty of Biotechnology and Life Science, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Applied Life Science Department, Faculty of Biotechnology and Life Science, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakiko","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Saga University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rintaro","family":"Sogawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Saga University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisato","family":"Shimanoe","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Saga University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"334","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Advani, R. H., Buggy, J. J., Sharman, J. P., Smith, S. M., Boyd, T. E., Grant, B., et al. (2013) Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed\/refractory B-cell malignancies. J. Clin. Oncol. 31; 88\u201394.","DOI":"10.1200\/JCO.2012.42.7906"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Chen, J., Zeng, F., Forrester, S. J., Eguchi, S., Zhang, M. Z. and Harris, R. C. (2016) Expression and function of the epidermal growth factor receptor in physiology and disease. Physiol. Rev. 96; 1025\u20131069.","DOI":"10.1152\/physrev.00030.2015"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Cheng, S., Ma, J., Guo, A., Leonard, J. P., Coleman, M., Liu, M., et al. (2014) BTK inhibition targets <i>in vivo<\/i> CLL proliferation through its effects on B-cell receptor signaling activity. Leukemia 28; 649\u2013657.","DOI":"10.1038\/leu.2013.358"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Evers, D. L., Fowler, C. B., Cunningham, B. R., Mason, J. T. and O\u2019Leary, T. J. (2011) The effect of formaldehyde fixation on RNA: optimization of formaldehyde adduct removal. J. Mol. Diagn. 13; 282\u2013288.","DOI":"10.1016\/j.jmoldx.2011.01.010"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Fujiwara, K., Shin, M., Yoshizaki, Y., Miyazaki, T. and Saita, T. (2011) Immunocytochemistry for bestatin and its application to drug accumulation studies in rat intestine and kidney. J. Mol. Histol. 42; 589\u2013596.","DOI":"10.1007\/s10735-011-9365-z"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Habeeb, A. F. (1966) Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal. Biochem. 14; 328\u2013336.","DOI":"10.1016\/0003-2697(66)90275-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Herman, S. E. M., Gordon, A. L., Hertlein, E., Ramanunni, A., Zhang, X., Jaglowski, S., et al. (2011) Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765. Blood 117; 6287\u20136296.","DOI":"10.1182\/blood-2011-01-328484"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Honigberg, L. A., Smith, A. M., Sirisawad, M., Verner, E., Loury, D., Chang, B., et al. (2010) The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc. Natl. Acad. Sci. U S A 107; 13075\u201313080.","DOI":"10.1073\/pnas.1004594107"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Leblond, C. P. and Stevens, C. E. (1948) The constant renewal of the intestinal epithelium in the albino rat. Anat. Rec. 100; 357\u2013377.","DOI":"10.1002\/ar.1091000306"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Moran, R., Darzynkiewicz, Z., Staiano-Coico, L. and Melamed, M. R. (1985) Detection of 5-bromodeoxyuridine (BrdUrd) incorporation by monoclonal antibodies: role of the DNA denaturation step. J. Histochem. Cytochem. 33; 821\u2013827.","DOI":"10.1177\/33.8.3860561"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Paydas, S. (2019) Management of adverse effects\/toxicity of ibrutinib. Crit. Rev. Oncol. Hematol. 136; 56\u201363.","DOI":"10.1016\/j.critrevonc.2019.02.001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Scheers, E., Leclercq, L., de Jong, J., Bode, N., Bockx, M., Laenen, A., et al. (2015) Absorption, metabolism, and excretion of oral 14C radiolabeled ibrutinib: an open-label, phase I, single-dose study in healthy men. Drug Metab. Dispos. 43; 289\u2013297.","DOI":"10.1124\/dmd.114.060061"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Tang, C. P. S., McMullen, J. and Tam, C. (2017) Cardiac side effects of bruton tyrosine kinase (BTK) inhibitors. Leuk. Lymphoma 59; 1554\u20131564.","DOI":"10.1080\/10428194.2017.1375110"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Treon, S. P., Gustine, J., Meid, K., Yang, G., Xu, L., Liu, X., et al. (2018) Ibrutinib monotherapy in symptomatic, treatment-na\u00efve patients with waldenstr\u00f6m macroglobulinemia. J. Clin. Oncol. 36; 2755\u20132761.","DOI":"10.1200\/JCO.2018.78.6426"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Van Sebille, Y. Z. A., Gibson, R. J., Wardill, H. R., Secombe, K. R., Ball, I. A., Keefe, D. M. K., et al. (2017) Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats. Int. J. Cancer 140; 2820\u20132829.","DOI":"10.1002\/ijc.30699"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Waller, E. K., Miklos, D., Cutler, C., Arora, M., Jagasia, M. H., Pusic, I., et al. (2019) Ibrutinib for chronic graft-versus-host disease after failure of prior therapy: 1-year update of a phase 1b\/2 study. Biol. Blood Marrow Transplant. 25; 2002\u20132007.","DOI":"10.1016\/j.bbmt.2019.06.023"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Wang, M. L., Rule, S., Martin, P., Goy, A., Auer, R., Kahl, B. S., et al. (2013) Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N. Engl. J. Med. 369; 507\u2013516.","DOI":"10.1056\/NEJMoa1306220"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Wells, A. (1999) EGF receptor. Int. J. Biochem. Cell Biol. 31; 637\u2013643.","DOI":"10.1016\/S1357-2725(99)00015-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Yamamoto, Y., Saita, T., Yamamoto, Y., Sogawa, R., Kimura, S., Narisawa, Y., et al. (2019) Immuno\u00adhistochemical localization of afatinib in male rat intestines and skin after its oral administration. Acta Histochem. 121; 151439.","DOI":"10.1016\/j.acthis.2019.09.001"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Yamamoto, Y., Saita, T., Oka, A., Kataoka, H. and Shin, M. (2019) Localization and Accumulation Studies of Dacomitinib in Rat Intestines and Skin by Immunohistochemistry. Acta Histochem. Cytochem. 52; 101\u2013106.","DOI":"10.1267\/ahc.19031"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Yamamoto, Y., Saita, T., Kataoka, H., Sogawa, R., Kimura, S., Kimura, S., et al. (2023) Localization of Sites of Osimertinib Action in Rat Intestine, Skin, and Lung by Immunohistochemistry. Acta Histochem. Cytochem. 56; 145\u2013151.","DOI":"10.1267\/ahc.23-00055"}],"container-title":["ACTA HISTOCHEMICA ET CYTOCHEMICA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ahc\/58\/2\/58_24-00053\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:38:51Z","timestamp":1746247131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ahc\/58\/2\/58_24-00053\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1267\/ahc.24-00053","relation":{},"ISSN":["0044-5991","1347-5800"],"issn-type":[{"value":"0044-5991","type":"print"},{"value":"1347-5800","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"article-number":"24-00053"}}